Overactive Bladder
Exploring lifelong overactive bladder: Transitions, evidence, and clinical implications; A modified Delphi process.
February 4, 2024
Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment.
February 4, 2024
Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists.
January 28, 2024
What is the best first choice oral drug therapy for OAB?
January 28, 2024
Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment.
January 28, 2024
Clinical tools for evaluating the severity of overactive bladder: A systematic review of psychometric properties.
January 21, 2024
Current optimal pharmacologic therapies for overactive bladder.
January 14, 2024
Real-World Evidence for Risk Factors of Bruises and Fractures from Falls in Patients with Overactive Bladder: A Medical Record Analysis.
January 7, 2024
How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system.
December 31, 2023
Response to tibial and sacral nerve modulation in overactive bladder: Is there any correlation?
December 31, 2023
Real-world onabotulinumtoxinA treatment patterns in patients with overactive bladder.
December 31, 2023